美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Niagen Bioscience

2.58

-0.0500-1.90%

盘后：2.580.00000.00%19:47 EDT

成交量：63.65万

成交额：164.58万

市值：2.05亿

市盈率：13.57

高：2.64

开：2.63

低：2.55

收：2.63

52周最高：7.95

52周最低：2.55

股本：7,964.43万

流通股本：5,581.92万

量比：1.55

换手率：1.14%

股息：- -

股息率：- -

每股收益(TTM):0.1901

每股收益(LYR):0.2000

净资产收益率：21.80%

总资产收益率：5.44%

市净率：2.49

市盈率(LYR):12.90

数据加载中...

总览公司新闻资讯公告

Niagen Bioscience与Mass General Brigham研究人员签署启动协议，开展首创性健康衰老临床试验

Niagen Bioscience：部分商业伙伴持续面临激烈竞争，原料业务预计不及上年

Niagen Bioscience预计：Niagen Plus增长与新护肤合作将从2027年起成重要驱动力

Niagen Bioscience将于8月4日发布二季度财报

环球市场播报

Niagen股价上涨，因其候选药物获美国和欧盟罕见病认定

Niagen Bioscience旗下NB4168获美国FDA授予罕见儿科疾病认定及欧洲EMA孤儿药产品认定，用于治疗共济失调毛细血管扩张症

Niagen Bioscience根据2026年6月26日销售协议可能出售至多5000万美元普通股 - 美国证券交易委员会文件披露

Niagen Bioscience强化NAD+全球领导地位外部研究项目更名

环球市场播报

国家广告审查委员会建议Niagen修改或停止部分Tru Niagen NAD+膳食补充剂宣传主张

Niagen Bioscience将Olympia Pharmaceuticals纳入Niagen Plus™ 503B复合药物合作伙伴网络

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/NAGE/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","market":"US","secType":"STK","nameCN":"Niagen Bioscience","latestPrice":2.58,"timestamp":1791921600000,"preClose":2.63,"halted":0,"volume":636469,"hourTrading":{"tag":"盘后","latestPrice":2.58,"preClose":2.58,"latestTime":"19:47 EDT","volume":9043,"amount":23331.9,"timestamp":1791935235757,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.019011406844106397,"floatShares":55819168,"shares":79644327,"eps":0.190148,"marketStatus":"未开盘","change":-0.05,"latestTime":"10-13 16:00:00 EDT","open":2.63,"high":2.64,"low":2.55,"amount":1645811.0723616,"amplitude":0.034221,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.190148,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791964800000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":2.63,"preHourTrading":{"tag":"盘前","latestPrice":2.62,"preClose":2.63,"latestTime":"09:28 EDT","volume":502,"amount":1337.9778892000002,"timestamp":1791898130080,"change":-0.01,"changeRate":-0.003802,"amplitude":0.030418},"postHourTrading":{"tag":"盘后","latestPrice":2.58,"preClose":2.58,"latestTime":"19:47 EDT","volume":9043,"amount":23331.9,"timestamp":1791935235757,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.55395,"impliedVol":1.1359,"impliedVolPercentile":0.3347},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","floatShares":55819168,"roa":"5.44%","roe":"21.80%","lyrEps":0.2,"volumeRatio":1.55395,"shares":79644327,"dividePrice":0,"high":2.64,"amplitude":0.034221,"preClose":2.63,"low":2.55,"week52Low":2.55,"pbRate":"2.49","psRate":"1.59","week52High":7.95,"institutionHeld":0,"latestPrice":2.58,"eps":0.190148,"divideRate":0,"volume":636469,"delay":0,"ttmEps":0.190148,"open":2.63,"prevYearClose":6.36,"prevWeekClose":2.69,"prevMonthClose":2.92,"prevQuarterClose":2.92,"fiveDayClose":2.69,"twentyDayClose":3,"sixtyDayClose":3.37},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"NAGE","fiscalQuarterEnding":"2026/06","expectedEps":0.01,"name":null,"time":"盘后","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"post","actualEps":0.01},{"market":"US","date":"2026-05-06","symbol":"NAGE","fiscalQuarterEnding":"2026/03","expectedEps":0.06,"name":null,"time":"盘后","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2026-03-04","symbol":"NAGE","fiscalQuarterEnding":"2025/12","expectedEps":0.02,"name":null,"time":"盘后","type":"earning","dateTimestamp":1772600400000,"reportTimeType":"post","actualEps":0.03},{"market":"US","date":"2025-11-04","symbol":"NAGE","fiscalQuarterEnding":"2025/09","expectedEps":0.02,"name":null,"time":"盘后","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":0.05},{"market":"US","date":"2025-08-06","symbol":"NAGE","fiscalQuarterEnding":"2025/06","expectedEps":0.02,"name":null,"time":"盘后","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":0.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1783396800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NAGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NAGE","date":"2026-10-12","current":13.568378,"percent":0.007673,"low":13.189881,"twenty":15.520424,"median":25.462771,"eighty":54.217538,"high":80.643552,"avg":33.775703,"sd":19.719208,"marketCap":213298175},"quantilePoints":[{"date":"2025-03-21","current":69.624479,"twenty":69.806742,"median":70.080136,"eighty":70.353531,"marketCap":595289295},{"date":"2025-03-28","current":67.346191,"twenty":68.676711,"median":69.624479,"eighty":70.371757,"marketCap":575809933},{"date":"2025-04-04","current":60.420196,"twenty":62.662031,"median":67.938546,"eighty":69.697384,"marketCap":516592673},{"date":"2025-04-11","current":51.67157,"twenty":54.861173,"median":62.880747,"eighty":69.551574,"marketCap":441791924},{"date":"2025-04-17","current":59.600012,"twenty":54.815607,"median":61.696037,"eighty":69.259953,"marketCap":509580103},{"date":"2025-04-25","current":67.255059,"twenty":55.043436,"median":62.151694,"eighty":68.530901,"marketCap":575030758},{"date":"2025-05-02","current":68.895427,"twenty":55.954751,"median":62.880747,"eighty":69.442216,"marketCap":589055899},{"date":"2025-05-09","current":51.710369,"twenty":55.954751,"median":65.022337,"eighty":70.535794,"marketCap":729374756},{"date":"2025-05-16","current":58.761783,"twenty":54.815607,"median":62.789615,"eighty":69.71561,"marketCap":828834951},{"date":"2025-05-23","current":56.859021,"twenty":55.043436,"median":61.650471,"eighty":69.624479,"marketCap":801996485},{"date":"2025-05-30","current":60.552618,"twenty":55.242319,"median":61.364091,"eighty":69.478669,"marketCap":854094682},{"date":"2025-06-06","current":64.414107,"twenty":55.822209,"median":61.604905,"eighty":69.296406,"marketCap":908560979},{"date":"2025-06-13","current":79.132535,"twenty":56.409541,"median":62.698483,"eighty":70.55402,"marketCap":1116164400},{"date":"2025-06-20","current":77.117845,"twenty":56.623974,"median":63.647427,"eighty":71.912091,"marketCap":1087747202},{"date":"2025-06-27","current":77.341699,"twenty":56.791865,"median":65.523561,"eighty":75.181504,"marketCap":1090904668},{"date":"2025-07-03","current":71.129739,"twenty":57.426855,"median":65.645306,"eighty":75.483707,"marketCap":1003284974},{"date":"2025-07-11","current":65.981088,"twenty":58.471876,"median":66.48476,"eighty":75.192697,"marketCap":930663244},{"date":"2025-07-18","current":57.950311,"twenty":58.471876,"median":65.645306,"eighty":75.114348,"marketCap":817389135},{"date":"2025-07-25","current":51.87826,"twenty":56.758286,"median":65.022337,"eighty":74.190401,"marketCap":731742856},{"date":"2025-08-01","current":52.325969,"twenty":55.224884,"median":64.358143,"eighty":72.732275,"marketCap":738057789},{"date":"2025-08-08","current":43.320593,"twenty":54.318273,"median":62.947882,"eighty":72.15947,"marketCap":768030786},{"date":"2025-08-15","current":43.771379,"twenty":53.985743,"median":62.607352,"eighty":71.628921,"marketCap":776022782},{"date":"2025-08-22","current":44.041851,"twenty":52.415511,"median":61.650471,"eighty":71.37484,"marketCap":780817979},{"date":"2025-08-29","current":44.267244,"twenty":51.68709,"median":61.280145,"eighty":71.129739,"marketCap":784813977},{"date":"2025-09-05","current":42.013311,"twenty":50.71606,"median":60.552618,"eighty":71.083855,"marketCap":744853999},{"date":"2025-09-12","current":43.365671,"twenty":45.745824,"median":60.318517,"eighty":70.845641,"marketCap":768829986},{"date":"2025-09-19","current":45.709762,"twenty":45.222912,"median":59.50888,"eighty":70.6087,"marketCap":810388363},{"date":"2025-09-26","current":42.419019,"twenty":45.024566,"median":58.520194,"eighty":70.371757,"marketCap":752046795},{"date":"2025-10-03","current":33.268051,"twenty":44.46559,"median":56.887002,"eighty":69.697384,"marketCap":589809282},{"date":"2025-10-10","current":34.079467,"twenty":44.02382,"median":56.607185,"eighty":69.623328,"marketCap":604194874},{"date":"2025-10-17","current":33.448366,"twenty":43.66319,"median":55.29204,"eighty":69.583421,"marketCap":593006080},{"date":"2025-10-24","current":33.448366,"twenty":43.41075,"median":54.929521,"eighty":69.405763,"marketCap":593006080},{"date":"2025-10-31","current":32.050928,"twenty":43.28453,"median":54.228731,"eighty":69.187048,"marketCap":568230894},{"date":"2025-11-07","current":25.87441,"twenty":42.455082,"median":54.050915,"eighty":68.822522,"marketCap":528588317},{"date":"2025-11-14","current":27.403352,"twenty":42.022327,"median":53.333314,"eighty":68.390298,"marketCap":559823081},{"date":"2025-11-21","current":26.30565,"twenty":34.151593,"median":52.437896,"eighty":67.731548,"marketCap":537398122},{"date":"2025-11-28","current":26.540872,"twenty":33.854074,"median":52.018169,"eighty":67.346191,"marketCap":542203471},{"date":"2025-12-05","current":26.266446,"twenty":33.628681,"median":51.67157,"eighty":67.255059,"marketCap":536597231},{"date":"2025-12-12","current":25.992021,"twenty":33.448366,"median":50.903505,"eighty":67.255059,"marketCap":530990991},{"date":"2025-12-19","current":25.482373,"twenty":32.772186,"median":49.393282,"eighty":66.988433,"marketCap":520579403},{"date":"2025-12-26","current":25.913613,"twenty":32.474667,"median":46.160548,"eighty":66.182557,"marketCap":529389208},{"date":"2026-01-02","current":24.933522,"twenty":30.002996,"median":45.709762,"eighty":65.94751,"marketCap":509366924},{"date":"2026-01-09","current":25.717595,"twenty":27.520963,"median":45.43929,"eighty":65.757233,"marketCap":525384751},{"date":"2026-01-16","current":24.737504,"twenty":27.019156,"median":45.168818,"eighty":65.594939,"marketCap":505362467},{"date":"2026-01-23","current":24.619893,"twenty":26.909386,"median":44.627874,"eighty":65.546241,"marketCap":502959792},{"date":"2026-01-30","current":23.482987,"twenty":26.540872,"median":44.492638,"eighty":65.122582,"marketCap":479733942},{"date":"2026-02-06","current":20.111473,"twenty":26.282128,"median":44.267244,"eighty":64.478311,"marketCap":410857283},{"date":"2026-02-13","current":19.954658,"twenty":25.944976,"median":44.008043,"eighty":64.391721,"marketCap":407653717},{"date":"2026-02-20","current":19.366604,"twenty":25.843047,"median":43.816458,"eighty":64.134289,"marketCap":395640346},{"date":"2026-02-27","current":20.307491,"twenty":25.623506,"median":43.591065,"eighty":63.1941,"marketCap":414861740},{"date":"2026-03-06","current":23.545172,"twenty":25.529418,"median":43.41075,"eighty":62.988163,"marketCap":409262188},{"date":"2026-03-13","current":22.252496,"twenty":25.411807,"median":43.320593,"eighty":62.862521,"marketCap":386792892},{"date":"2026-03-20","current":21.88316,"twenty":25.058974,"median":43.095199,"eighty":62.753162,"marketCap":380373093},{"date":"2026-03-27","current":20.636651,"twenty":24.761026,"median":42.599334,"eighty":62.487416,"marketCap":358706271},{"date":"2026-04-02","current":20.867486,"twenty":24.619893,"median":42.419019,"eighty":62.007672,"marketCap":362718645},{"date":"2026-04-10","current":20.682818,"twenty":24.345467,"median":42.035851,"eighty":61.696037,"marketCap":359508746},{"date":"2026-04-17","current":21.836993,"twenty":23.875024,"median":35.567063,"eighty":61.604905,"marketCap":379570618},{"date":"2026-04-24","current":21.836993,"twenty":23.545172,"median":34.102007,"eighty":61.448036,"marketCap":379570618},{"date":"2026-05-01","current":21.836993,"twenty":23.175836,"median":33.854074,"eighty":61.280145,"marketCap":379570618},{"date":"2026-05-08","current":18.041368,"twenty":22.760333,"median":33.696298,"eighty":61.168218,"marketCap":336236974},{"date":"2026-05-15","current":16.273169,"twenty":22.34483,"median":33.493445,"eighty":60.552618,"marketCap":303283042},{"date":"2026-05-22","current":16.230344,"twenty":22.248072,"median":33.448366,"eighty":60.552618,"marketCap":302484929},{"date":"2026-05-29","current":16.444465,"twenty":22.012428,"median":33.155355,"eighty":60.44668,"marketCap":306475495},{"date":"2026-06-05","current":14.988445,"twenty":21.873927,"median":32.772186,"eighty":60.257509,"marketCap":279339644},{"date":"2026-06-12","current":14.688676,"twenty":21.735571,"median":32.546792,"eighty":59.723377,"marketCap":273752851},{"date":"2026-06-18","current":14.431731,"twenty":21.468256,"median":32.208703,"eighty":59.545333,"marketCap":268964171},{"date":"2026-06-26","current":14.174786,"twenty":20.98752,"median":28.148222,"eighty":59.396403,"marketCap":264175492},{"date":"2026-07-02","current":14.260435,"twenty":20.867486,"median":27.834592,"eighty":59.097565,"marketCap":265771718},{"date":"2026-07-10","current":14.945621,"twenty":20.636651,"median":27.324945,"eighty":58.568512,"marketCap":278541531},{"date":"2026-07-17","current":14.560203,"twenty":20.370149,"median":27.050519,"eighty":58.147287,"marketCap":271358511},{"date":"2026-07-24","current":13.660897,"twenty":20.127155,"median":26.95251,"eighty":57.524987,"marketCap":254598133},{"date":"2026-07-31","current":14.21761,"twenty":20.033066,"median":26.893705,"eighty":56.881406,"marketCap":264973605},{"date":"2026-08-07","current":15.07415,"twenty":19.767151,"median":26.540872,"eighty":56.825443,"marketCap":241050726},{"date":"2026-08-14","current":15.123736,"twenty":19.424638,"median":26.403659,"eighty":56.657552,"marketCap":241843656},{"date":"2026-08-21","current":15.619596,"twenty":18.243689,"median":26.266446,"eighty":56.409541,"marketCap":249772956},{"date":"2026-08-28","current":15.917112,"twenty":16.632891,"median":26.011623,"eighty":55.822209,"marketCap":254530536},{"date":"2026-09-04","current":15.421252,"twenty":16.410206,"median":25.913613,"eighty":55.269655,"marketCap":246601236},{"date":"2026-09-11","current":15.049357,"twenty":16.273169,"median":25.835206,"eighty":55.180113,"marketCap":240654261},{"date":"2026-09-18","current":14.826219,"twenty":16.059048,"median":25.737197,"eighty":55.043436,"marketCap":237086075},{"date":"2026-09-25","current":14.925392,"twenty":15.844927,"median":25.560781,"eighty":54.815607,"marketCap":238671936},{"date":"2026-10-02","current":13.289053,"twenty":15.716455,"median":25.541179,"eighty":54.452586,"marketCap":212505245},{"date":"2026-10-09","current":13.189881,"twenty":15.520424,"median":25.482373,"eighty":54.228731,"marketCap":210919385},{"date":"2026-10-12","current":13.338639,"twenty":15.520424,"median":25.462771,"eighty":54.217538,"marketCap":213298175}],"updateTime":1791960814221},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAGE\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1113232842","title":"Niagen Bioscience与Mass General Brigham研究人员签署启动协议，开展首创性健康衰老临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1113232842","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113232842?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 20:36","pubTimestamp":1790771812,"startTime":"0","endTime":"0","summary":"Niagen Bioscience宣布，已与Mass General Brigham（MGB）的研究人员达成启动协议，将共同推进一项具有开创意义的健康衰老临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAGE","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155120533","title":"Niagen Bioscience：部分商业伙伴持续面临激烈竞争，原料业务预计不及上年","url":"https://stock-news.laohu8.com/highlight/detail?id=1155120533","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155120533?lang=zh_cn&edition=fundamental","pubTime":"2026-08-05 04:20","pubTimestamp":1785874850,"startTime":"0","endTime":"0","summary":"Niagen Bioscience 发布预警：由于部分商业合作伙伴继续在竞争更加激烈的市场中挣扎，公司原料业务板块的业绩预计将低于去年同期水平。这一预期意味着，外部市场环境的恶化正在对公司的核心业务造成显著压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128164693","title":"Niagen Bioscience预计：Niagen Plus增长与新护肤合作将从2027年起成重要驱动力","url":"https://stock-news.laohu8.com/highlight/detail?id=1128164693","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128164693?lang=zh_cn&edition=fundamental","pubTime":"2026-08-05 04:17","pubTimestamp":1785874648,"startTime":"0","endTime":"0","summary":"Niagen Bioscience对外释放积极信号，表示其旗舰产品Niagen Plus的持续增长以及一系列全新的护肤品战略合作，预计将从2027年开始，逐步转化为公司业绩中举足轻重的贡献者。这一预期标志着公司对未来增长引擎的清晰布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","NAGE","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653036272","title":"Niagen Bioscience将于8月4日发布二季度财报","url":"https://stock-news.laohu8.com/highlight/detail?id=2653036272","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653036272?lang=zh_cn&edition=fundamental","pubTime":"2026-07-21 21:46","pubTimestamp":1784641560,"startTime":"0","endTime":"0","summary":"专注于NAD+与健康老龄化科学的Niagen Bioscience公司宣布，将于2026年8月4日（周二）美股盘后公布第二季度财务业绩。公司将于当天下午4点30分举行网络直播会议，讨论财报结果并更新业务进展。　　公司此前发布的第一季度财报显示，总净销售额增长3%至3150万美元，其中Tru Niagen产品贡献2240万美元。公司近期在产品线拓展方面取得多项进展：推出了Niagen Plus居家注射套装及远程医疗功能，并试水了Niagen NanoCloud护肤产品线，预计10月全面推广。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-21/doc-iniiqquw9233142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NAGE","PSET","SQMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651774111","title":"Niagen股价上涨，因其候选药物获美国和欧盟罕见病认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2651774111","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651774111?lang=zh_cn&edition=fundamental","pubTime":"2026-07-13 20:50","pubTimestamp":1783947000,"startTime":"0","endTime":"0","summary":"BUZZ-Niagen股价上涨，因其候选药物获美国和欧盟罕见病认定7月13日-** 生物技术公司Niagen Bioscience（NAGE.O）的股价在盘前交易中上涨2.6%，至3.47美元** 该公司表示，其试验性药物NB4168已获得美国和欧洲针对共济失调-毛细血管扩张症的罕见病认定，该病是一种罕见的遗传性疾病，会影响运动功能、削弱免疫系统并增加患癌风险** 公司表示，这些认定提供了监管激励","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nL4T43F12T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAGE","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138170641","title":"Niagen Bioscience旗下NB4168获美国FDA授予罕见儿科疾病认定及欧洲EMA孤儿药产品认定，用于治疗共济失调毛细血管扩张症","url":"https://stock-news.laohu8.com/highlight/detail?id=1138170641","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138170641?lang=zh_cn&edition=fundamental","pubTime":"2026-07-13 20:32","pubTimestamp":1783945941,"startTime":"0","endTime":"0","summary":"生物技术公司Niagen Bioscience宣布，其候选药物NB4168用于治疗共济失调毛细血管扩张症（A-T）的研发，已获得美国食品药品监督管理局（FDA）授予的罕见儿科疾病（RPD）认定，以及欧洲药品管理局（EMA）授予的孤儿药产品（OMPD）认定。这两项认定标志着该药物在针对这一严重罕见疾病的开发进程中取得了重要监管进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","NAGE","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160802853","title":"Niagen Bioscience根据2026年6月26日销售协议可能出售至多5000万美元普通股 - 美国证券交易委员会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1160802853","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160802853?lang=zh_cn&edition=fundamental","pubTime":"2026-06-29 18:20","pubTimestamp":1782728418,"startTime":"0","endTime":"0","summary":"根据一份向美国证券交易委员会提交的文件，Niagen Bioscience公司依据一份日期为2026年6月26日的股权销售协议，可能出售价值高达5000万美元的公司普通股。该协议为公司提供了通过市场运作，在特定时期内逐步出售股票以筹集资金的途径。此举通常旨在为公司的运营、研发或其他企业活动提供资金支持，同时根据市场条件和公司需求灵活执行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAGE","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640941274","title":"Niagen Bioscience强化NAD+全球领导地位 外部研究项目更名","url":"https://stock-news.laohu8.com/highlight/detail?id=2640941274","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640941274?lang=zh_cn&edition=fundamental","pubTime":"2026-06-02 23:09","pubTimestamp":1780412940,"startTime":"0","endTime":"0","summary":"NAD+科学领域的全球权威企业Niagen Bioscience宣布，将其广受认可的“ChromaDex外部研究项目”正式更名为“Niagen研究项目”。此举紧随公司从ChromaDex更名为Niagen Bioscience的战略步伐，旨在通过其旗舰成分Niagen，集中力量推进对NAD+的理解与应用。　　此外，公司还启动了“Niagen Bioscience培训生资助计划”，每年将向专注于运动表现、恢复、疲劳及适应性等方向的研究生和博士后提供三项1万美元的资助，以培养下一代NAD+科研人才。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-02/doc-inhzzumh2976932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4183","NAD","BK4121","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124900345","title":"国家广告审查委员会建议Niagen修改或停止部分Tru Niagen NAD+膳食补充剂宣传主张","url":"https://stock-news.laohu8.com/highlight/detail?id=1124900345","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124900345?lang=zh_cn&edition=fundamental","pubTime":"2026-05-21 22:32","pubTimestamp":1779373939,"startTime":"0","endTime":"0","summary":"国家广告审查委员会已提出建议，要求Niagen公司对其Tru Niagen NAD+膳食补充剂的某些宣传主张进行修改或完全停止使用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAGE","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115416670","title":"Niagen Bioscience将Olympia Pharmaceuticals纳入Niagen Plus™ 503B复合药物合作伙伴网络","url":"https://stock-news.laohu8.com/highlight/detail?id=1115416670","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115416670?lang=zh_cn&edition=fundamental","pubTime":"2026-04-28 20:37","pubTimestamp":1777379832,"startTime":"0","endTime":"0","summary":"Niagen Bioscience宣布与Olympia Pharmaceuticals达成合作，后者正式加入其503B复合药物合作伙伴网络，共同推进明星产品Niagen Plus™的市场布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4121","BK4183"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}